Controlled Substances: Scheduling, Dispensing, Monitoring, and Records
Scheduling and the paper trail
The Controlled Substances Act places substances in Schedules I–V by abuse potential and accepted medical use. Schedule I has no accepted medical use; Schedule II has high abuse potential with severe dependence liability and no refills; III–V step down. A substance is controlled if listed in either the federal or the Pennsylvania schedule - check both, because a state may add or restrict. Every handler needs a DEA registration for each location, and Schedule II purchases use DEA Form 222 or its electronic equivalent (CSOS). A biennial inventory is required on any date within two years of the prior inventory, and records - invoices, dispensing data, destruction documents - are kept at least two years. Theft or significant loss is reported on DEA Form 106; destruction is documented on DEA Form 41 or through a reverse distributor. Schedule II requires a written, electronic, or emergency oral prescription, with a follow-up written prescription within seven days for the oral route; III–V may be refilled up to five times within six months. Partial filling is allowed under defined conditions. Corresponding responsibility requires the pharmacist - not the software - to resolve red flags before dispensing. Pennsylvania's PDMP requires dispenser reporting and prescriber queries in defined circumstances.
Traps
Assuming a Schedule II can be refilled "just once"; believing Form 222 is required for Schedule III; assuming state and federal schedules always match; delegating red-flag judgment to the computer; treating a PDMP printout as a substitute for documented clinical reasoning.
Rule of thumb
Before a controlled substance leaves the counter: valid prescriber, valid patient relationship, PDMP check where required, red flags resolved, and the transaction documented so a stranger could reconstruct it.